ASN: PPIs Associated With Increased Risk of Kidney Disease
Risk for both chronic kidney disease, end-stage renal disease higher with proton pump inhibitor use
ASN: Tolvaptan Slows eGFR Decline in Later-Stage ADPKD
Reduction in decline in eGFR for patients with later-stage autosomal dominant polycystic kidney disease
ACR: Temporary Cessation of MTX Ups Flu Shot Immunogenicity
Findings in patients with rheumatoid arthritis taking a stable dose of methotrexate
ACR: Opioids, SSRIs Tied to Higher Fracture Risk in RA
Increased risk of osteoporotic fracture with selective serotonin reuptake inhibitors, opioids of any strength
Tezacaftor-Ivacaftor, Ivacaftor Alone Effective in CF
And tezacaftor-ivacaftor effective for cystic fibrosis patients homozygous for CFTR Phe508del mutation
ACR: Successful Tapering of DMARDs in RA Explored
Low level of serum CRP at baseline linked to successful down-titration in multivariate analysis
CYP2C19-Genotype Guided Antiplatelet Tx May Be Beneficial
MACE risk up with clopidogrel versus alternative therapy for patients with CYP2C19 loss-of-function allele
Drop in Proportion of Neonates With Long IV Therapy for UTI
Decrease from 50 percent in 2005 to 19 percent in 2015; not linked to increase in hospital readmissions
PARP Inhibitors Promising Beyond BRCA1/2 Altered Tumors
Talazoparib caused regression in 5 patient-derived xenografts, 4 without germline BRCA1/2 mutations
American College of Allergy, Asthma and Immunology, Oct. 26-30
The 2017 Annual Meeting of the American College of Allergy, Asthma & Immunology The annual meeting of the American College of...
